Quick Answer
IMPACT BIOMEDICAL INC. reported Cash And Cash Equivalents At Carrying Value of $3.0 thousand for the year ending 2025.
- IMPACT BIOMEDICAL INC. showed a decrease of -99.8% in Cash And Cash Equivalents At Carrying Value from 2024 to 2025.
- This data is from IMPACT BIOMEDICAL INC.'s annual report (Form 10-K), filed with the SEC on March 11, 2026.
- XBRL data for this metric is available from 2022 to 2025 (4 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q2 2023: $3.0 thousand | Q3 2023: $201.0 thousand | Q1 2024: $2.0 thousand | Q2 2024: $2.0 thousand | Q3 2024: $2.67 million | Q1 2025: $1.32 million | Q2 2025: $624.0 thousand | Q3 2025: $12.0 thousand.
- Over the full 4 years of available data (2022 to 2025), IMPACT BIOMEDICAL INC.'s Cash And Cash Equivalents At Carrying Value has grown by 50.0%.
- Historical annual values: Fiscal year 2025: $3.0 thousand | Fiscal year 2024: $2.00 million | Fiscal year 2023: $1.0 thousand | Fiscal year 2022: $2.0 thousand.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: